Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title	Grant Number Sort descending	Program Official
Labaer, Joshua	Arizona State University-Tempe Campus United States	Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck	5R33CA281802-03	Wendy Wang, Ph.D., M.Sc.
Permuth, Jennifer B	H. Lee Moffitt Cancer Ctr & Res Inst United States	Using Radiogenomics to Noninvasively Predict the Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Uncover Hidden Biology	5R37CA229810-07	Matthew Young, Ph.D.
Bettegowda, Chetan	Johns Hopkins University United States	Interrogating malignant gliomas using released tumor DNA in cerebrospinal fluid	5R37CA230400-07	Sidney Fu, M.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-05	Matthew Young, Ph.D.
Salkowski, Lonie	University Of Wisconsin-Madison United States	Defining and Optimizing Critical Interpretation Skills in Screening Mammography to Improve Cancer Detection	5R37CA262110-04	Guillermo Marquez, Ph.D.
Nappi, Lucia	Provincial Health Services Authority United States	Integrating investigational miR371a-3p with conventional radiology imaging for earlier and more precise detection of active germ cell malignancy: A BCC/SWOG/S1823 secondary use of data collaboration.	5R37CA264798-03	Guillermo Marquez, Ph.D.
Stachler, Matthew D	University Of California, San Francisco United States	Optimization and validation of a biomarker panel for risk stratification in Barrett's esophagus	5R37CA269649-04	Matthew Young, Ph.D.
Salami, Simpa Samuel	University Of Michigan At Ann Arbor United States	Defining the Biological Arc of Grade Group 1 Prostate Cancer	5R37CA283857-03	Guillermo Marquez, Ph.D.
Lin, Jia-Ren	Harvard Medical School United States	Advancing technologies for the collection and analysis of high dimensional immunoprofiles and tumor images	5R50CA274277-04	Guillermo Marquez, Ph.D.
Dhakal, Soma	Virginia Commonwealth University United States	Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers	5R61CA278445-03	Christos Patriotis, Ph.D., M.Sc.
Sanda, Martin G	Emory University United States	Prostate Cancer Biomarker and Imaging Validation Alliance: Emory University, University of Alabama Birmingham, and University of Texas Southwestern	5U01CA113913-18	Indu Kohaar, Ph.D., M.Phil., M.Sc.
Li, Christopher I	Fred Hutchinson Cancer Center United States	Fred Hutchinson Breast Cancer Clinical Validation Center	5U01CA152637-15	Sidney Fu, M.D.
Bast, Robert C	University Of Tx Md Anderson Can Ctr United States	MD Anderson Cancer Center EDRN- Clinical Validation Center for Early Detection of Ovarian Cancer with a multiple marker algorithm	5U01CA200462-08	Christos Patriotis, Ph.D., M.Sc.
Heine, John J	H. Lee Moffitt Cancer Ctr & Res Inst United States	Quantitative Imaging Clinical Validation Center at Moffitt Cancer Center	5U01CA200464-08	Guillermo Marquez, Ph.D.
Brand, Randall	University Of Pittsburgh At Pittsburgh United States	Validation of biomarkers for risk prediction and early diagnosis of Pancreatic Adenocarcinoma	5U01CA200466-08	Matthew Young, Ph.D.